Pregnancy-Associated Atypical Hemolytic Uremic Syndrome: A Systematic Review.
CONCLUSION: Pregnancy-associated aHUS usually presents in the postpartum period, often after a pregnancy complication, and eculizumab is effective for achieving disease remission.
SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD42019129266.
PMID: 31809447 [PubMed - as supplied by publisher]
Source: Obstetrics and Gynecology - Category: OBGYN Authors: Gupta M, Govindappagari S, Burwick RM Tags: Obstet Gynecol Source Type: research
More News: Corticosteroid Therapy | Databases & Libraries | Dialysis | Gastroenteritis | Genetics | Hemolytic Uremic Syndrome (HUS) | OBGYN | Pregnancy | Renal Failure | Science | Study | Thrombocytopenia | Women